Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Ipsen - March 2025 - Monthly information relative to the total number of voting…
Monthly information relative to the total number of voting rightsand shares composing the share capital(in accordance with Article L.233-8 II of the French Commercial Code andArticle 223-16 of the General Regulation of theAutorité des Marchés Financiers ) Market: Euronext ParisISIN Code: FR 0010259150 LEI: 549300M6SGDPB4Z94P11 DateTotal number of shares composing the share capitalTotal number of voting rights(1) 31 March 202583,814,526Gross total* ...
Nasdaq GlobeNewswire
14/04/2025
Valneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya…
Saint Herblain (France), April 14, 2025–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to its single-dose vaccine IXCHIQ ®for the prevention of disease caused by the chikungunya virus in individuals 18 years of age and older. The ANVISA decision marks the world's first approval of a chikungunya vaccine in an endemic country. Part of Valneva's endemic...
Nasdaq GlobeNewswire
14/04/2025
US Clinical Communication & Collaboration Market worth US$1.57 billion by 2029…
Browse in-depth TOC on "US Clinical Communication & Collaboration Market" Browse in-depth TOC on "US Clinical Communication & Collaboration Market" 190 - Tables60 - Figures By Based on component,the US, the Clinical Communication and Collaboration market is segmented into hardware, software, and services segment. The software segment accounted for the largest share of the component segment in 2023. The software segment comprises clinical alerting &…
PR Newswire
14/04/2025
With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz
VANCOUVER, BC, April 14, 2025 /PRNewswire/ -- Equity InsiderNews Commentary – Routine medical appointments or cancer screenings—critical for catching the disease in earlier, more treatable stages—has dropped to just over 50% of the population. At the same time, doctors are raising alarm bells over a noticeable increase in cancer diagnoses among younger adults, especially women. With proposed funding cuts to the NIH now on the table and new estimates suggesting that drug tariffs could add $10,000…
PR Newswire
14/04/2025
[Corrected] Sandoz files antitrust litigation against Amgen regarding patient…
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules – corrected: reference to date of product launch in Europe removed; link to “Important Safety Information” updated Company aims to accelerate access to much-needed biosimilar to reference medicine Enbrel®* for US patients with disabling inflammatory diseasesDespite FDA approval nearly a decade ago, etanercept biosimilar continues to be blockedSandoz seeking damages in addition to clearing path for launch ...
Nasdaq GlobeNewswire
14/04/2025
Kedrion Biopharma closes 2024 with a growth of +10% and unveils its new identity
2024 was an important year for Kedrion, marking double-digit growth, with turnover reaching 1,578 million Euro, an increase of +10% compared to 2023. EBITDA reported increased by 28% to 232 million Euro, while adjusted EBITDA rose by 20% to 279 million Euro. Additionally, improved margins and disciplined financial management generated positive cash flow, fully funding investments and strengthening operations. 2024 was an important year for Kedrion, marking double-digit growth, with…
PR Newswire
14/04/2025
Transactions in Connection with Share Buy-back Program
Company Announcement COPENHAGEN, Denmark; April 14, 2025 – Genmab A/S (Nasdaq: GMAB).On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restricted Stock Unit program. The share buy-back program is expected to be completed no later than July 10, 2025.The following transactions were executed under the program from April 7 to April 11, 2025: Trading Platform...
Nasdaq GlobeNewswire
14/04/2025
Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation…
INNOVERA™ is engineered with plant-based proteins, biopolymers and post-consumer waste to replicate the look and feel of the collagen found in leather. With over 80% renewable carbon content, it provides an animal-free solution that integrates into industry standard manufacturing processes. INNOVERA™, offered in various colors, haptics and finishes, is lightweight and twice as strong as traditional leather. INNOVERA™ is engineered with plant-based proteins, biopolymers and post-consumer waste...
PR Newswire
14/04/2025
Sidekick Health Cracks the Code on Medication Adherence -- Driving Better…
A Smarter Approach to Adherence A Smarter Approach to Adherence Sidekick's new, integrated offering combines two of their flagship product categories into a single solution that unifies the patient experience into a single, seamless care journey and improves disease management for patients. And, it's built to deliver better outcomes and lower healthcare costs for payers while offering greater adherence, persistence, and patient health outcomes for life sciences organizations: "Even the...
PR Newswire
14/04/2025
Transactions under Novonesis' share buyback program
Please read the announcement in PDF Attachment 2025_18_Share_buyback_program
Nasdaq GlobeNewswire
14/04/2025
SKF completes previously announced divestment of its ring and seal operation in…
Aerospace will remain a large, strategic segment also after the divestment with a share of industrial sales corresponding to approximately 9 percent. Investments in strengthening core aeroengine and structure bearing offerings remain a priority for SKF. Aerospace will remain a large, strategic segment also after the divestment with a share of industrial sales corresponding to approximately 9 percent. Investments in strengthening core aeroengine and structure bearing offerings remain a…
PR Newswire
14/04/2025
AMDI Launches Autolab™ HBH at ESCMID 2025, Redefining Sample Prep for Molecular…
"The Autolab™ HBH system was developed to overcome the longstanding challenges in sample prep—namely complexity, cost, and time," said David Okrongly, CEO of AMDI. "This launch reflects our ongoing mission to deliver advanced tools that generalize and thus improve molecular laboratory workflows and enable broader access to high-quality molecular testing, from PCR to sequencing." "The Autolab™ HBH system was developed to overcome the longstanding challenges in sample…
PR Newswire
14/04/2025
Sandoz files antitrust litigation against Amgen regarding patient access to…
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Company aims to accelerate access to much-needed biosimilar to reference medicine Enbrel® *for US patients with disabling inflammatory diseasesDespite FDA approval nearly a decade ago, etanercept biosimilar continues to be blockedSandoz seeking damages in addition to clearing path for launch Basel, April 14, 2025 –Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today...
Nasdaq GlobeNewswire
14/04/2025
European Commission approves Roche's Columvi as the first bispecific antibody…
Approval based on Phase III STARGLO study where Columvi in combination with chemotherapy showed a 41% reduction in the risk of death compared to MabThera/Rituxan plus chemotherapy 1,2 DLBCL is an aggressive cancer with a high risk of progression meaning urgent and effective treatments are needed for people who relapse or have refractory diseaseThis Columvi regimen offers a much needed off-the-shelf and fixed-duration treatment option for those ineligible for transplant Basel,...
Nasdaq GlobeNewswire
14/04/2025
Press release: CMS Proposes Approval of Additional Payment for Sequana Medical's…
CMS Proposes Approval of Additional Payment for Sequana Medical's alfapump® system in Hospital Inpatient CasesNew Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2026 Rule, expected to be finalized in August 2025 and in effect by October 1, 2025Launch centers on track to complete training by end of Aprilalfapump® US commercial launch remains on track for Q3 2025 through specialty commercial team focused on liver transplant centersPMA approval...
Nasdaq GlobeNewswire
14/04/2025
Celebrating 75 Years of Scandinavian Innovation: ASKO Launches Groundbreaking…
From energy-efficient laundry systems to innovative kitchen solutions, ASKO has continually set new standards in functionality and design. Its exhibition at Milan Design Week showcases the ASKO Attention to Detail design approach that combines meticulous craftsmanship with forward-thinking innovations to create products that are both beautiful and highly functional. From energy-efficient laundry systems to innovative kitchen solutions, ASKO has continually set new standards in functionality and…
PR Newswire
14/04/2025
CMEF Shanghai 2025 Wraps Up in Shanghai with Record-Breaking Innovations and…
Revolutionizing Healthcare: Key Product Launches Revolutionizing Healthcare: Key Product Launches CMEF 2025 featured thousands of groundbreaking product launches that are set to transform healthcare delivery. Here are some of the highlights: This edition's CMEF International Zone featured a new "Novel Product Pavilion" dedicated to showcasing cutting-edge medical technologies from SMEs worldwide. Notable national pavilions includedItaly'sTrade Agency (ITA) with leaders in IVD,...
PR Newswire
14/04/2025
Fruitful translation of HKBU's innovative research projects takes centre stage…
Gold Medal with Congratulations of the Jury Gold Medal with Congratulations of the Jury Gold Medal Silver Medal Bronze Medal Aspiring to be a leading research-led university inAsiafor the world, HKBU engages in cutting-edge, innovative and transdisciplinary research and knowledge transfer endeavours that push the boundaries of knowledge, address global issues, and contribute to the well-being of both local and international communities. HKBU's award winning projects...
PR Newswire
13/04/2025
Over 3 million children died from AMR-related infections in 2022, major study…
The study data found that in 2022 alone, more than 752,000 children in Southeast Asia and 659,000 children in Africa died of AMR-associated complications. Many of these deaths were linked to the use of Watch antibiotics (drugs with a high risk of resistance) and Reserve antibiotics(last-resort treatments for severe, multidrug-resistant infections). The study data found that in 2022 alone, more than 752,000 children inSoutheast Asiaand 659,000 children inAfricadied of AMR-associated…
PR Newswire
13/04/2025
DBV Technologies announces filing of 2024 Annual Report on Form 10-K and…
DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need (the “Company”), today announced: The audited financial statements for the year ended December 31, 2024 were approved by the Board of Directors...
Nasdaq GlobeNewswire
11/04/2025
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as…
Disclosure of Share Capital and Voting Rights Outstandingas of March 31, 2025(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)Paris, France (April 11, 2025 - 6:00 pm)– As of March 31, 2025, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as...
Nasdaq GlobeNewswire
11/04/2025
EssilorLuxottica: First-Quarter 2025 Revenue Conference Call Invitation
First-Quarter 2025 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our First-Quarter 2025 Revenue Conference Call on: Wednesday, April 23, 2025, at 6:30 pm CEST Dial-in telephone access:If you wish to dial into the conference call, please pre-register at the following link to receive the personal credentials (Dial-in numbers, Conference ID and User ID): https://grid...
Nasdaq GlobeNewswire
11/04/2025
Africa IVD Market to Reach $1.7 Billion by 2032, Growing at a CAGR of 3.1% from…
Browse in-depth scope of Africa IVD Market Report: Browse in-depth scope of Africa IVD Market Report: 242 – Tables 55 – Figures 110 – Pages For more comprehensive insights, download the FREE report sample:https://www.meticulousresearch.com/download-sample-report/cp_id=5415 KEY MARKET DRIVERS AND TRENDS The Africa IVD market is being propelled by several key drivers and emerging trends that are reshaping the diagnostic landscape across the...
PR Newswire
11/04/2025
Industrial Fasteners Market to Reach $126.8 Billion, Globally, by 2033 at 3.6%…
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A35356 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A35356 Macroeconomic & Geopolitical Impact The industrial fasteners market is significantly influenced by macroeconomic and geopolitical factors, shaping both demand and supply dynamics. Economic growth and industrialization drive demand for fasteners in key sectors such as...
PR Newswire
11/04/2025
Altri Comunicati
